scholarly article | Q13442814 |
P819 | ADS bibcode | 1984PNAS...81.7363B |
P356 | DOI | 10.1073/PNAS.81.23.7363 |
P953 | full work available at URL | http://www.pnas.org/content/81/23/7363.full.pdf |
https://europepmc.org/articles/PMC392146 | ||
https://europepmc.org/articles/PMC392146?pdf=render | ||
https://pnas.org/doi/pdf/10.1073/pnas.81.23.7363 | ||
P932 | PMC publication ID | 392146 |
P698 | PubMed publication ID | 6334307 |
P5875 | ResearchGate publication ID | 16862596 |
P2093 | author name string | W. C. Barker | |
L. T. Hunt | |||
M. C. Blomquist | |||
P2860 | cites work | Isolation and characterization of a cDNA coding for human factor IX | Q24629231 |
A simple method for displaying the hydropathic character of a protein | Q26778481 | ||
Empirical Predictions of Protein Conformation | Q28300310 | ||
Complete amino acid sequence of the light chain of human blood coagulation factor X: evidence for identification of residue 63 as beta-hydroxyaspartic acid | Q28646341 | ||
Construction of phylogenetic trees | Q29547497 | ||
Prediction of protein antigenic determinants from amino acid sequences | Q29547548 | ||
Establishing homologies in protein sequences | Q29618225 | ||
Enhanced graphic matrix analysis of nucleic acid and protein sequences | Q30501600 | ||
The gene structure of human anti-haemophilic factor IX. | Q33939512 | ||
The origin and evolution of protein superfamilies | Q34008976 | ||
Comparison of amino acid sequence of bovine coagulation Factor IX (Christmas Factor) with that of other vitamin K-dependent plasma proteins | Q34035629 | ||
Origins of Prokaryotes, Eukaryotes, Mitochondria, and Chloroplasts | Q34102135 | ||
The primary structure of human urogastrone | Q34161583 | ||
The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin | Q34255489 | ||
Partial primary structure of bovine plasma fibronectin: Three types of internal homology | Q34707857 | ||
Bovine factor X1 (Stuart factor): amino-acid sequence of heavey chain | Q35085728 | ||
Instability and reiteration of DNA sequences within the vaccinia virus genome | Q35326399 | ||
Biologically active synthetic fragments of epidermal growth factor: localization of a major receptor-binding region | Q36251141 | ||
Mapping of the vaccinia virus thymidine kinase gene by marker rescue and by cell-free translation of selected mRNA | Q36282848 | ||
General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. | Q36913229 | ||
Complete nucleotide sequences of two adjacent early vaccinia virus genes located within the inverted terminal repetition. | Q36926805 | ||
Transforming growth factors produced by retrovirus-transformed rodent fibroblasts and human melanoma cells: amino acid sequence homology with epidermal growth factor | Q37344260 | ||
Epidermal growth factor. Location of disulfide bonds | Q38485969 | ||
Local aggregation of hormone–receptor complexes is required for activation by epidermal growth factor | Q40226398 | ||
A non-mitogenic analogue of epidermal growth factor enhances the phosphorylation of endogenous membrane proteins | Q44361850 | ||
Expression of the vaccinia virus genome: analysis and mapping of mRNAs encoded within the inverted terminal repetition | Q45791145 | ||
Structure of a mouse submaxillary messenger RNA encoding epidermal growth factor and seven related proteins | Q48397396 | ||
Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli | Q48400430 | ||
Molecular cloning and characterization of cDNA sequences coding for rat relaxin | Q48409691 | ||
Conformation and unfolding thermodynamics of epidermal growth factor and derivatives | Q52849080 | ||
Rat Transforming Growth Factor Type 1: Structure and Relation to Epidermal Growth Factor | Q53553601 | ||
Cellular responsiveness to growth factors correlates with a cell's ability to express the transformed phenotype | Q54495304 | ||
Amino-Acid Sequence of Human Insulin | Q59067248 | ||
Amino acid sequence of the heavy chain of bovine protein C. | Q64968491 | ||
Proinsulin and the biosynthesis of insulin | Q68603507 | ||
The primary structure of epidermal growth factor | Q69387018 | ||
Purification and primary structure of a polypeptide with multiplication-stimulating activity from rat liver cell cultures. Homology with human insulin-like growth factor II | Q70153901 | ||
The cell attachment domain of fibronectin. Determination of the primary structure | Q70254555 | ||
Primary structure of human plasma fibronectin. The 29,000-dalton NH2-terminal domain | Q71070840 | ||
The primary structure of high molecular mass urokinase from human urine. The complete amino acid sequence of the A chain | Q71454192 | ||
Amino acid sequence of the light chain of bovine factor X1 (Stuart factor) | Q71494197 | ||
Amino acid sequence of the light chain of bovine protein C | Q71861539 | ||
Blood coagulation | Q72147522 | ||
Unexpected relationships between bacteriophage lambda hypothetical proteins and bacteriophage T4 tail-fiber proteins | Q72796464 | ||
P433 | issue | 23 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | virology | Q7215 |
Vaccinia virus | Q1986297 | ||
P304 | page(s) | 7363-7 | |
P577 | publication date | 1984-12-01 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Vaccinia virus 19-kilodalton protein: relationship to several mammalian proteins, including two growth factors | |
P478 | volume | 81 |
Q40791679 | A mitogenic signal triggered at an early stage of vaccinia virus infection: implication of MEK/ERK and protein kinase A in virus multiplication. |
Q36874703 | Analysis and organization of protein sequence data: a retrospective spanning four decades |
Q42679073 | Analysis of the monkeypox virus genome |
Q34369297 | Bacteriophage PRD1 DNA polymerase: evolution of DNA polymerases |
Q37800922 | Camelpox: epidemiology, diagnosis and control measures |
Q42813576 | Characterization of the mouse Tdgf1 gene and Tdgf pseudogenes |
Q40130035 | Characterization of vaccinia virus growth factor biosynthetic pathway with an antipeptide antiserum |
Q37414612 | Cleavage of the membrane precursor for transforming growth factor alpha is a regulated process |
Q36908904 | DNA sequence homology between the terminal inverted repeats of Shope fibroma virus and an endogenous cellular plasmid species |
Q36876074 | Deletion of the vaccinia virus growth factor gene reduces virus virulence |
Q42856543 | Disulphide bridges of bovine factor X. |
Q36844512 | Epidermal growth factor and transforming growth factor α |
Q45837541 | Epidermal growth factor receptor occupancy inhibits vaccinia virus infection |
Q36655979 | Evidence for intracellular down-regulation of the epidermal growth factor (EGF) receptor during adenovirus infection by an EGF-independent mechanism |
Q24312598 | Expression cloning of a novel scavenger receptor from human endothelial cells |
Q37480208 | Expression of human epidermal growth factor precursor cDNA in transfected mouse NIH 3T3 cells |
Q40372624 | Functional organization of variola major and vaccinia virus genomes |
Q30229267 | Genomic differences of Vaccinia virus clones from Dryvax smallpox vaccine: the Dryvax-like ACAM2000 and the mouse neurovirulent Clone-3. |
Q37167213 | Growth Factor Receptors |
Q72259916 | HER4 receptor activation and phosphorylation of Shc proteins by recombinant heregulin-Fc fusion proteins |
Q35607469 | Homology between DNA polymerases of poxviruses, herpesviruses, and adenoviruses: nucleotide sequence of the vaccinia virus DNA polymerase gene |
Q28115244 | Human epidermal growth factor precursor: cDNA sequence, expression in vitro and gene organization |
Q58969683 | Integral membrane glycoprotein properties of the prohormone pro-transforming growth factor-α |
Q35830307 | Isolation of a monoclonal antibody which blocks vaccinia virus infection. |
Q37392431 | Localization and sequence of a vaccinia virus gene required for multiplication in human cells |
Q36886902 | Mapping and sequencing of a gene from myxoma virus that is related to those encoding epidermal growth factor and transforming growth factor alpha |
Q67802653 | Mapping the receptor-recognition site of human transforming growth factor-α |
Q36426104 | Molecular cloning, encoding sequence, and expression of vaccinia virus nucleic acid-dependent nucleoside triphosphatase gene |
Q38610595 | Molecular mimicry as a mechanism for virus-induced autoimmunity |
Q36884106 | Multiple 3' ends of mRNA encoding vaccinia virus growth factor occur within a series of repeated sequences downstream of T clusters |
Q36692178 | New gene, nel, encoding a Mr 93 K protein with EGF‐like repeats is strongly expressed in neural tissues of early stage chick embryos |
Q36902103 | Nucleotide sequence of a full-length human endogenous retroviral segment |
Q42657008 | Pathogenic poxviruses reveal viral strategies to exploit the ErbB signaling network |
Q37785595 | Potential role of the epidermal growth factor receptor in human pancreatic cancer. |
Q34055804 | Poxvirus homologues of cellular genes |
Q24634729 | Poxvirus pathogenesis |
Q24322471 | Protein structure of fetal antigen 1 (FA1). A novel circulating human epidermal-growth-factor-like protein expressed in neuroendocrine tumors and its relation to the gene products of dlk and pG2 |
Q40874339 | Reovirus receptors |
Q69875933 | Retroviral gag and DNA endonuclease coding sequences in IgE-binding factor gene |
Q36729738 | Retrovirus-mediated transfer of an adenovirus gene encoding an integral membrane protein is sufficient to down regulate the receptor for epidermal growth factor |
Q28507065 | SREC-II, a new member of the scavenger receptor type F family, trans-interacts with SREC-I through its extracellular domain |
Q24299121 | Sequence of the cDNA encoding the laminin B1 chain reveals a multidomain protein containing cysteine-rich repeats |
Q24617135 | Sequence of the notch locus of Drosophila melanogaster: relationship of the encoded protein to mammalian clotting and growth factors |
Q53518356 | Shope fibroma: a model system to study tumorigenesis by poxviruses. |
Q59098143 | Similarity of vaccinia 28K, v-erb-B and EGF receptors |
Q24594594 | Solution structure of the epidermal growth factor-like domain of heregulin-alpha, a ligand for p180erbB-4 |
Q42041069 | Stimulation of cell motility by a viral fibroblast growth factor homolog: proposal for a role in viral pathogenesis |
Q39698408 | Structural and functional aspects of epidermal growth factor (EGF) and its receptor. |
Q40650419 | Structure-function analysis of synthetic and recombinant derivatives of transforming growth factor alpha |
Q40645600 | Substitution of lysine for arginine at position 42 of human transforming growth factor-alpha eliminates biological activity without changing internal disulfide bonds |
Q24297663 | Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor |
Q36694749 | The 10,400- and 14,500-dalton proteins encoded by region E3 of adenovirus form a complex and function together to down-regulate the epidermal growth factor receptor |
Q26269835 | The LDL receptor gene: a mosaic of exons shared with different proteins |
Q40043247 | The epidermal growth factor receptor is not a receptor for vaccinia virus. |
Q36834422 | The genome of Shope fibroma virus, a tumorigenic poxvirus, contains a growth factor gene with sequence similarity to those encoding epidermal growth factor and transforming growth factor alpha |
Q41704313 | The molecular biology of swinepox virus II. The infectious cycle |
Q36667899 | The tanapoxvirus 15L protein is a virus-encoded neuregulin that promotes viral replication in human endothelial cells |
Q33811821 | The vaccinia virus A9L gene encodes a membrane protein required for an early step in virion morphogenesis |
Q36852325 | Transcription of vaccinia virus early genes by a template-dependent soluble extract of purified virions |
Q36854635 | Transcriptional and translational mapping and nucleotide sequence analysis of a vaccinia virus gene encoding the precursor of the major core polypeptide 4b |
Q35608343 | Transforming growth factor alpha inhibits secretion of gastric acid |
Q36767000 | Transforming growth factor alpha: an aromatic side chain at position 38 is essential for biological activity |
Q36785343 | Transforming growth factor alpha: mutation of aspartic acid 47 and leucine 48 results in different biological activities |
Q36728801 | Understanding orthopoxvirus interference with host immune responses to inform novel vaccine design |
Q35854551 | Vaccinia virions lacking core protein VP8 are deficient in early transcription |
Q45828839 | Vaccinia virus encodes a polypeptide homologous to epidermal growth factor and transforming growth factor |
Q28297889 | Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins |
Q36909038 | Vaccinia virus growth factor stimulates tyrosine protein kinase activity of A431 cell epidermal growth factor receptors |
Q37527595 | Vaccinia virus-infected cells release a novel polypeptide functionally related to transforming and epidermal growth factors |
Q39318787 | Viral exploitation of the MEK/ERK pathway - A tale of vaccinia virus and other viruses |
Q39585494 | Viral vascular endothelial growth factor plays a critical role in orf virus infection. |
Q41374895 | Virocrine transformation |
Q35221338 | What's new in the role of cytokines on osteoblast proliferation and differentiation? |
Q34587973 | beta-Hydroxyasparagine in domains homologous to the epidermal growth factor precursor in vitamin K-dependent protein S |